- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Price disconnect
Taiwanese Pharmaceuticals & Biotech Price disconnect
Results
7
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
7 companies
TTY Biopharm
Market Cap: NT$19.3b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$77.80
7D
1.8%
1Y
1.4%
Cenra
Market Cap: NT$5.2b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$35.65
7D
4.9%
1Y
5.9%
Maxigen Biotech
Market Cap: NT$3.6b
Researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$40.40
7D
1.0%
1Y
-7.3%
Allied Biotech
Market Cap: NT$2.7b
Engages in the manufacture and sale of carotenoids worldwide.
1780
NT$24.85
7D
3.3%
1Y
43.6%
Vetnostrum Animal Health
Market Cap: NT$2.4b
Engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed.
6936
NT$32.40
7D
0.2%
1Y
-10.2%
TSH Biopharm
Market Cap: NT$1.9b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$50.40
7D
1.4%
1Y
4.1%
Chi Sheng Pharma & Biotech
Market Cap: NT$1.7b
Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.
4111
NT$28.85
7D
-3.7%
1Y
-8.7%